返回 Agenda
Debunking Decentralized Trials: Sharing Breakthroughs and Deal Breakers
Session Chair(s)
Jane Myles, MSC
Program Director
Jemtech Co, United States
In this forum, a panel of experts will share their experience on the breakthroughs -what really works, and the deal breakers -what’s not working yet or was harder than expected. Our aim is to debunk the decentralized trial hype and share lessons learned. The forum will include perspectives from a sponsor, a decentralized trial vendor, a 'site' and if possible, a patient who has participated in a decentralized trial.
Learning Objective : Discuss key learnings about what's working and not working in decentralized trials; Discuss individual experiences on design and implementation of decentralized trials; Describe the patient and site perspective on participation in decentralized trials.
Speaker(s)
Panelist
Leonard Sacks, MD
FDA, United States
Director, Clinical Methodologies,Office of Medical Policy, CDER
Panelist
Komathi Stem, MS
Glooko, United States
Chief Operating Officer
Panelist
Gerrit Hamre, MA
Duke-Margolis Institute For Health Policy (DMI), United States
Research Director